Literature DB >> 11044362

Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage.

A Nehmé1, B L Lee, R Baskaran, Q Zhang, X Lin, R D Christen.   

Abstract

DNA damage has been shown to activate c-Abl tyrosine kinase. We now report that, in addition to DNA damage, microtubule damage induced by paclitaxel results in activation of c-Abl kinase. In 3T3 cells, the presence of c-Abl kinase increased paclitaxel-induced cell death. In Abl-proficient cells, paclitaxel produced a marked and prolonged G2/M arrest which peaked at 24 h and a rapid and marked induction of p21(WAF1)which also peaked at 24 h. In Abl-deficient cells, the G2/M arrest induced by paclitaxel was less prominent and shorter in duration and the effect of paclitaxel on p21(WAF1)expression was reduced and delayed. Paclitaxel had no effect on p53 expression and MAPK phosphorylation. These findings indicate that, in 3T3 cells, c-Abl kinase facilitates cell death and regulates G2/M arrest in response to paclitaxel-induced microtubule damage in a pathway that is dependent on p21(WAF1)and independent of MAPK activity. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044362      PMCID: PMC2408779          DOI: 10.1054/bjoc.2000.1440

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

Review 1.  Abl tyrosine kinase in signal transduction and cell-cycle regulation.

Authors:  J Y Wang
Journal:  Curr Opin Genet Dev       Date:  1993-02       Impact factor: 5.578

2.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

Review 3.  Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

4.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.

Authors:  D W Nicholson; A Ali; N A Thornberry; J P Vaillancourt; C K Ding; M Gallant; Y Gareau; P R Griffin; M Labelle; Y A Lazebnik
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

5.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

6.  Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways.

Authors:  M S Sheikh; X S Li; J C Chen; Z M Shao; J V Ordonez; J A Fontana
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

Review 7.  Taxol: mechanisms of action and resistance.

Authors:  S B Horwitz; D Cohen; S Rao; I Ringel; H J Shen; C P Yang
Journal:  J Natl Cancer Inst Monogr       Date:  1993

8.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

9.  Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.

Authors:  M B Datto; Y Li; J F Panus; D J Howe; Y Xiong; X F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 10.  Preclinical evaluation of docetaxel (Taxotere).

Authors:  F Lavelle; M C Bissery; C Combeau; J F Riou; P Vrignaud; S André
Journal:  Semin Oncol       Date:  1995-04       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.